Basics Array Technologies, Inc. Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. IPO Date: October 15, 2020 Sector: Technology Industry: Solar Market Cap: $1B Activated in VL: True Average Daily Range Avg Daily Range: $0.53 | 3.24% Avg Daily Range (30 D): $0.26 | 4.26% Avg Daily Range (90 D): $0.22 | 3.74% Institutional Daily Volume Avg Daily Volume: 4.19M Avg Daily Volume (30 D): 6.99M Avg Daily Volume (90 D): 5.19M Trade Size Avg Trade Size (Sh.): 119 Avg Trade Size (Sh.) (30 D): 154 Avg Trade Size (Sh.) (90 D): 150 Institutional Trades Total Inst.Trades: 5,424 Avg Inst. Trade: $2.27M Avg Inst. Trade (30 D): $2.37M Avg Inst. Trade (90 D): $2.15M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $5.06M Avg Closing Trade (30 D): $3.49M Avg Closing Trade (90 D): $3.07M Avg Closing Volume: 338.71K     News Jun 6, 2025 @ 4:03 PM Record $3.3 Trillion Global Energy Investment: Whi... Source: Surbhi Jain May 6, 2025 @ 11:00 AM ARRAY Technologies, Inc. Reports Financial Results... Source: Array Technologies, Inc. Jan 27, 2025 @ 2:00 PM ARRAY Technologies Names Gina Gunning as Chief Leg... Source: Array Technologies Dec 4, 2024 @ 2:00 PM ARRAY Technologies and RP Surpass 6GW of Solar Pow... Source: N/A Nov 4, 2024 @ 9:05 PM Why Solar Energy Stocks Skyrocketed Today Source: Travis Hoium Financials   TTM Q3 2024 Q2 2024 Basic EPS $.02 $-1.02 $.08 Diluted EPS $.02 $-1.02 $.08 Revenue $ 302.36M $ 231.41M $ 255.77M Gross Profit $ 76.43M $ 78.32M $ 85.95M Net Income / Loss $ 16.75M $ -141.35M $ 25.7M Operating Income / Loss $ 27.28M $ -132.68M $ 39.6M Cost of Revenue $ 225.94M $ 153.09M $ 169.81M Net Cash Flow $ -14.65M $ 50.05M $ -5.3M PE Ratio 383.00